High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis

NCT00939549 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study revised to retrospective chart review

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: Cyclophosphamide/Glatiramer acetate

Sponsor

Johns Hopkins University